Remedee Labs, has obtained medical device status in Europe for its millimeter wave endorphin stimulator wristband.

Remedee Labs announces positive results from its clinical trial on osteoarthritis.

Remedee Labs, a French start-up that specializes in non-pharmaceutical chronic pain management and just announced the positive results of its

February 1st, 2023 – Today, the French pharmaceutical company UPSA and the startup Remedee Labs are announcing the signature of a

Remedee Labs, a French start-up that specializes in non-pharmaceutical treatments for chronic pain, is announcing a new €12.2 million funding

Remedee Labs, a Grenoble-based startup specializing in integrated chronic pain care centered on its unique endorphin stimulation technology, is joining

On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough

Remedee Labs, designer of the first endorphin stimulator for individual use, announces the arrival of Gilles LITMAN, formerly VP Digital

MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Their mission

The challenge of measuring endorphin levels The analgesic effect of millimeter wave (MMW) therapy is due to the release of

Funding to support new endorphin-stimulation pain therapy clinical trial Meylan, France, – 14 November 2019 – French startup Remedee Labs